Multiple Sclerosis (MS) Market Research Reports & Industry Analysis
The prevalence rate of MS in the United States is approximately 57.8 per 100,000. Above the 37th parallel, the prevalence is reported at 68.8 per 100,000, and below it, it is reported at 35.5 per 100,000 Scientists continue their extensive efforts to create new and better therapies for MS. One of the most promising MS research areas involves naturally occurring antiviral proteins known as interferons. Beta interferon has been shown to reduce the number of exacerbations and may slow the progression of physical disability.
When attacks do occur, they tend to be shorter and less severe. In addition, there are a number of treatments under investigation that may curtail attacks or improve function. Over a dozen clinical trials testing potential therapies are underway, and additional new treatments are being devised and tested in animal models. There are a variety of treatments for M.S. which are indicated to slow the progress of the disease.
Multiple Sclerosis (MS) Industry Research & Market Reports
-
Multiple Sclerosis Drugs Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Multiple Sclerosis Drugs
... at a CAGR of 6.7% over the analysis period 2024-2030. Immmunomoderator Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$13.2 Billion by the end of ... Read More
-
Medical Marijuana Market Size, Share, and Outlook, 2025 Report- By Product (Flower, Oil & Tinctures ), By Application (Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Post-Traumatic Stress Disorder (PTSD), Parkinson's Disease, Tourettes, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Medical Marijuana segments across 22 countries from 2021 to 2032. ... Read More
-
Multiple Sclerosis Therapeutics Market Size, Share, and Outlook, 2025 Report- By Drug (Large-molecule Drugs, Small-molecule Drugs), By Route of Administration (Oral, Injectable, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Multiple Sclerosis Therapeutics segments across 22 countries ... Read More
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Immunoassay for Neurological Biomarkers ... Read More
-
Continence Care Market Size, Share, and Outlook, 2025 Report- By Product (Urinary Catheters, Catheter Maintenance/Care, Urinary Bags), By Application (Diabetes, Strokes, BPH, Alzheimer, Cerebral Palsy, Parkinson, Prostate cancer, Spinal Cord Injury, Bladder Cancer, Multiple sclerosis, Spina Bifida, Others), By Bag Usage, Sterile bags, Non-sterile bags), By End-User (Home Care Settings, Hospitals, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Continence Care segments across 22 countries from 2021 to 2032. ... Read More
-
Active Wheelchair Market Size, Share, and Outlook, 2025 Report- By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Active Wheelchair segments across 22 countries from 2021 to 2032. ... Read More
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%. Favorable reimbursement policies in North America and Europe coupled with ... Read More
-
Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035
... and Region - Trends, Analysis, and Forecast till 2035 Neurological disorder diagnostics is the process of evaluating and identifying neurological disorder by performing neurological examination, patient’s medical history, and diagnostic tests, such as MRI and ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market ... Read More
-
North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... to 2031. Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled ... Read More
-
South & Central America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... from 2023 to 2031. Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Developments Fuels South & Central America Intermittent Catheters Market Benign prostatic hyperplasia (BPH) and prostatitis are among the most common reasons ... Read More
-
Middle East & Africa Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... from 2023 to 2031. Micro-Hole Zone Catheters Bolster Middle East & Africa Intermittent Catheters Market UTIs are common complications associated with intermittent catheterization (CIC), which hampers individuals’ quality of life and adds to their healthcare ... Read More
-
Asia Pacific Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... to 2031. Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Developments Boosts Asia Pacific Intermittent Catheters Market Benign prostatic hyperplasia (BPH) and prostatitis are among the most common reasons for intermittent self-catheterization in ... Read More
-
Europe Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson's Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), and End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others)
... 2031. Adoption of Single-Use Catheters Drives Europe Intermittent Catheters Market Single-use intermittent catheters have been linked with improved health outcomes, including a lower risk of urinary tract infections (UTIs), urethral trauma, and quality of life. ... Read More
-
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast ... Read More
-
Relapsing Remitting Multiple Sclerosis Market
... therapies. The market is projected to grow at a CAGR of 3.1% during the forecast period of 2024-2032, and likely to reach a value of 7.6 billion by 2032. Relapsing Remitting Multiple Sclerosis Market Analysis ... Read More
-
Global Active Wheelchair Market Size, Share & Trends Analysis by Type (Manual Wheelchair, Powered Wheelchair), by Indication (Cerebral Palsy, Alzheimer’s Disease, Multiple Sclerosis), and Regional Forecasts 2022–2032
... witness significant growth, with the market size estimated at USD 1.58 billion in 2023 and projected to expand at a CAGR of 5.8% during the forecast period from 2024 to 2032. These mobility aids are ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Neurorehabilitation Devices Market Analysis and Forecast To 2033: By Type (Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interface, Robotic Systems, Neuroprosthetics, Neurofeedback Systems), Product (Neurostimulation Devices, Neurorehabilitation Apps, Therapeutic Devices, Biofeedback Devices, Cognitive Training Tools), Services (Rehabilitation Therapy, Consultation Services, Training and Education, Maintenance and Support), Technology (Artificial Intelligence, Virtual Reality, Augmented Reality, Machine Learning, Internet Of Things, Cloud Computing), Application (Stroke Rehabilitation, Traumatic Brain Injury, Parkinson'S Disease, Multiple Sclerosis, Cerebral Palsy, Spinal Cord Injury), End User (Hospitals, Clinics, Rehabilitation Centers, Home Care Settings, Research Institutes), Device (Exoskeletons, Hand Function Systems, Gait Trainers, Balance Systems), Functionality (Motor Skills Enhancement, Cognitive Function Improvement, Speech Therapy, Vision Rehabilitation), Solut
... Therapy, Consultation Services, Training and Education, Maintenance and Support), Technology (Artificial Intelligence, Virtual Reality, Augmented Reality, Machine Learning, Internet Of Things, Cloud Computing), Application (Stroke Rehabilitation, Traumatic Brain Injury, Parkinson'S Disease, Multiple Sclerosis, Cerebral Palsy, ... Read More
-
Innovation Insights: B-cell Depletion
... used to treat conditions like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. B cells contribute to disease by producing autoantibodies, presenting antigens, and secreting cytokines. Therapies often target CD20, a marker on B cells, ... Read More
-
Global Stem Cell Therapy for Multiple Sclerosis Market Growth (Status and Outlook) 2024-2030
... million in 2023. With growing demand in downstream market, the Stem Cell Therapy for Multiple Sclerosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. ... Read More
-
Multiple Sclerosis Market in US 2025-2029
... the multiple sclerosis market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
Research Assistance
